CPChain successfully landed on ChainList, ushering in a new era of Web3
BlockBeats News, December 19th, according to official sources, CPChain has been officially included in the EVM Network Navigation Platform ChainList. This is not only a high recognition of CPChain's technical strength and network stability, but also an important milestone for CPChain to move towards a global Web3 ecosystem.
As an authoritative platform connecting millions of Web3 users, being listed on ChainList means that CPChain will receive greater exposure and more convenient wallet integration support.
In the future, CPChain will continue to expand its ecosystem boundaries, and together with more global Web3 users, build a more open and efficient blockchain world.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Laser uranium enrichment technology developer LIS Technologies (LIS.US) sets IPO price at $5-7 per share, aiming to raise $17 million
LIS Technologies plans to issue 2.8 million shares at a price range of $5 to $7 per share to raise $17 million.

Immunology and inflammation biotech company Bambusa (BBTX.US) prices IPO at $15-17 per share, aims to raise $150 million.
Bambusa Therapeutics plans to raise 150 millions USD by issuing 9.4 million shares at a price range of 15 to 17 USD per share.
The Bank of Japan’s price trend indicator rises above 3%, providing grounds for further rate hikes
The Bank of Japan's indicator for measuring underlying inflation has risen to its highest level in three years, far surpassing the bank's 2% target, providing grounds for authorities to continue raising interest rates.

$95 billion bet on AI! Meta (META.US) launches rare equity financing, while Goldman Sachs still maintains "Buy" rating
Meta announced a $95 billion equity financing, with NVIDIA, AMD, and Broadcom planning to subscribe $5 billion. Goldman Sachs reiterated its "buy" rating with a target price of $885.
